Please use this identifier to cite or link to this item:
|Title:||IP Strategy for Drug Discovery: A Dedicated Research Firm’s Perspective|
|Keywords:||IP strategy;Dedicated research firm;Drug discovery;Licensing;Knowledge management;IP portfolio|
|Abstract:||Even though, dedicated research firms rely heavily on the strength of their intellectual property (IP) to strike a favorable licensing deal, they seldom have the bandwidth to maintain a dedicated IP team to strategize the IP in a fashion which would enable them to reap the maximum value from the IP generated. The article discusses how to approach the issue of designing an IP strategy from a dedicated research firm point of view.|
|ISSN:||0975-1076 (Online); 0971-7544 (Print)|
|Appears in Collections:||JIPR Vol.17(5) [September 2012]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.